Identification and Management of Metabolic Syndrome: The Role of the APN

Douglas H. Sutton, EdD, MSN; Deborah A. Raines, PhD


Topics in Advanced Practice Nursing eJournal. 2007;7(2) 

In This Article


From a clinical perspective, the diagnosis of metabolic syndrome identifies a patient at increased risk for atherosclerotic CVD and/or type 2 DM. In an effort to introduce the syndrome into clinical practice, the AHA/NHLBI has attempted to formulate simple diagnostic criteria, and to avoid the emphasis of the development of the syndrome on a single cause.

It should be noted that some individuals or ethnic groups (for example, Asians) will develop characteristics of insulin resistance and metabolic syndrome with only moderate increases in waist circumference (that is, beginning at 37 in or 94 cm in men or 32 in or 80 cm in women).[2] Regardless of ethnicity or sex, once an individual exhibits 3 of the 5 AHA/NHLBI diagnostic criteria, they are considered to have metabolic syndrome.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: